2-138550278-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001001664.3(SPOPL):āc.62G>Cā(p.Ser21Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,613,476 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001001664.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPOPL | NM_001001664.3 | c.62G>C | p.Ser21Thr | missense_variant | 2/11 | ENST00000280098.9 | NP_001001664.1 | |
SPOPL | XM_047444116.1 | c.-68G>C | 5_prime_UTR_variant | 1/10 | XP_047300072.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPOPL | ENST00000280098.9 | c.62G>C | p.Ser21Thr | missense_variant | 2/11 | 1 | NM_001001664.3 | ENSP00000280098.4 | ||
SPOPL | ENST00000420679.1 | n.62G>C | non_coding_transcript_exon_variant | 1/11 | 5 | ENSP00000396006.1 | ||||
SPOPL | ENST00000430968.5 | n.62G>C | non_coding_transcript_exon_variant | 2/5 | 5 | ENSP00000410201.1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152080Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251048Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135676
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461396Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 726978
GnomAD4 genome AF: 0.000125 AC: 19AN: 152080Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74272
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 02, 2024 | The c.62G>C (p.S21T) alteration is located in exon 2 (coding exon 1) of the SPOPL gene. This alteration results from a G to C substitution at nucleotide position 62, causing the serine (S) at amino acid position 21 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at